UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Health outcomes of children with Prader-Willi or Angelman syndromes: a European population-based multicentre study

Abate, Maria Valentina; Barisic, Ingeborg; Santoro, Michele; Coi, Alessio; Tan, Joachim; Garne, Ester; Loane, Maria; ... Morris, Joan K; + view all (2025) Health outcomes of children with Prader-Willi or Angelman syndromes: a European population-based multicentre study. Archives of Disease in Childhood 10.1136/archdischild-2025-328786. (In press). Green open access

[thumbnail of Tan_Health outcomes of children with Prader-Willi or Angelman syndromes_AAM.pdf]
Preview
Text
Tan_Health outcomes of children with Prader-Willi or Angelman syndromes_AAM.pdf - Accepted Version

Download (443kB) | Preview
[thumbnail of Tan_Health outcomes of children with Prader-Willi or Angelman syndromes_SuppM.pdf]
Preview
Text
Tan_Health outcomes of children with Prader-Willi or Angelman syndromes_SuppM.pdf - Accepted Version

Download (392kB) | Preview

Abstract

BACKGROUND/AIM: Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are rare imprinting disorders caused by the aberrant expression of 15q11.2-q13 imprinted genes. Due to their rarity, data on health outcomes during infancy are limited. This EUROlinkCAT study aimed to investigate major health outcomes of children with these chromosomal disorders. METHODS: Data of children born in 1995-2014 and diagnosed with PWS (n=150) or AS (n=46), collected by 11 population-based congenital anomaly registries, were linked to local electronic healthcare and mortality databases and analysed. RESULTS: Children with PWS had a survival rate of 94% (95% CI 89.5% to 98.7%) by 10 years of age. Nearly all children (99.5%, 95% CI 97.6% to 99.9%) with PWS required hospitalisation during the first year of life with a median length of stay of 25 days; a high proportion continued to need hospital care later in life (93.2% at 1-4 years and 79.6% at 5-9 years) with shorter stays (1.2 and 0.5 days per year, respectively). In comparison, no deaths occurred among children with AS by 10 years of age. Fewer children with AS required hospitalisation in the first year of life (59.0%, 95% CI 39.6% to 74.0%); as they grew older, the proportion admitted was 68% (95% CI 40.0% to 85.0%) at 5-9 years. Children with PWS and AS underwent first surgery at approximately 1.8 years and 2.5 years, respectively. CONCLUSIONS: This study provides valuable evidence for improving family counselling and promoting an adequate healthcare support system.

Type: Article
Title: Health outcomes of children with Prader-Willi or Angelman syndromes: a European population-based multicentre study
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1136/archdischild-2025-328786
Publisher version: https://doi.org/10.1136/archdischild-2025-328786
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Population, Policy and Practice Dept
URI: https://discovery.ucl.ac.uk/id/eprint/10209797
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item